The Indian government has withdrawn a Bill introduced in 2013 to amend the existing Drugs and Cosmetics Act, promising to ‘comprehensively review’ regulations to suit new science and research methods.
It is all part of the government’s attempts to update the laws governing India’s pharmaceutical and medical devices industries, and two separate Acts are on their way to replace the legislation, one to regulate drugs and cosmetics, and the other for medical devices.
The government had earlier attempted to change regulations through amendments to the 1940 Drugs and Cosmetics Act by bringing in amendment bills between 2013 and 2015.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze